In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Marrone Bio Innovations Inc. (NASDAQ:MBII) reported that Bhatia Ranjeet has picked up 1,165,283 of common stock as of 2017-05-11.
The acquisition brings the aggregate amount owned by Bhatia Ranjeet to a total of 1,165,283 representing less than 3.7% stake in the company.
For those not familiar with the company, Marrone Bio Innovations, Inc. offers bio-based pest management and plant health products. The Company’s bio-based products include naturally occurring microorganisms, such as bacteria, fungi and plant extracts. It sells its products to crop protection market. Its four crop protection products include Regalia, Grandevo, Venerate and Majestene. Its products are used in both conventional and organic crop production, and are sold to growers of specialty crops, such as grapes, citrus, tomatoes, vegetables, nuts, leafy greens and ornamental plants. It offers Regalia for large-acre row crops, such as corn and soybeans. Its pipeline of early-stage discoveries and product candidates extends across a range of product types for end markets, including herbicides, fungicides, nematicides, insecticides, algaecides (for algae control), molluscicides (for mussel and snail control), and plant growth and plant stress regulators. It is engaged in developing MBI-010, MBI-110, Haven (MBI-505) and MBI-601.
A glance at Marrone Bio Innovations Inc. (NASDAQ:MBII)’s key stats reveals a current market capitalization of 44.79 Million based on 30.49 Million shares outstanding and a price at last close of $1.50 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-04-25, Ardsley picked up 50,000 at a purchase price of $1.72. This brings their total holding to 3,681,580 as of the date of the filing.
On the sell side, the most recent transaction saw Ardsley unload 1,189,700 shares at a sale price of $1.68. This brings their total holding to 2,491,880.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Marrone Bio Innovations Inc. (NASDAQ:MBII) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.